- ►endojournals.org M Cosma, BA Swiglo, DN Flynn, DM Kurtz, ML … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Context: Insulin sensitizers, including metformin and thiazolidinediones (TZDs),
improve hyperinsulinemia and reproductive dysfunctions in some women with
hyperandrogenism. The extent to which these agents improve hirsutism ... Cited by 21 - Related articles - BL Direct - All 4 versions
- ►uchile.cl [PDF] C Cerda, RM Pérez-Ayuso, A Riquelme, A Soza … - Journal of Hepatology, 2007 - Elsevier Forty-one PCOS patients (mean age: 24.6 ± 7.2 yr, mean body mass index [BMI]:
30.3 ± 7.0 kg/m 2 ) were included; 26 of 41 PCOS patients (63.4%) had insulin
resistance and 17 (41.5%) had NAFLD. Nine of the NAFLD patients (64%) also ... Cited by 22 - Related articles - All 16 versions
- ►endojournals.org BA Swiglo, M Cosma, DN Flynn, DM Kurtz, ML … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Context: The relative efficacy of antiandrogens for the treatment of hirsutism
remains unclear. ... Objective: We performed a systematic review and
metaanalyses of randomized controlled trials (RCTs) evaluating the effect ... Cited by 19 - Related articles - BL Direct - All 3 versions
A Dunaif… - Nature Clinical Practice Endocrinology and Metabolism, 2008 - medscape.com The recognition that insulin resistance has a pivotal role in the pathogenesis
of polycystic ovary syndrome (PCOS) revolutionized our understanding of this
complex disorder. PCOS causes major metabolic and reproductive morbidities, ... Cited by 18 - Related articles - BL Direct - All 5 versions
JD Cameron, JK Cruickshank - Clinical & Experimental Pharmacology & Physiology, 2007 - pt.wkhealth.com 2. Diabetes mellitus is associated with increased cardiovascular events, is an
established major independent risk factor for cardiovascular disease and is
included in current risk assessment algorithms. Based on Framingham risk ... Cited by 16 - Related articles - BL Direct - All 7 versions
- ►cell.com HJ Teede, SK Hutchison, S Zoungas - Trends in Endocrinology & Metabolism, 2007 - Elsevier Polycystic ovary syndrome (PCOS) has reproductive and metabolic implications.
Insulin resistance (IR), secondary to genetic and lifestyle factors, is integral
in the pathogenesis, metabolic, clinical features and the long-term ... Cited by 13 - Related articles - All 4 versions
S Palomba, A Falbo, F Zullo, F Orio Jr - Endocrine Reviews, 2009 - Endocrine Soc Metformin is an insulin sensitizer widely used for the treatment of patients
affected by type 2 diabetes mellitus. Because many women with polycystic ovary
syndrome (PCOS) are insulin resistant, metformin was introduced in clinical ... Cited by 13 - Related articles - All 6 versions
- ►diabetesjournals.org SK Hutchison, C Harrison, N Stepto, C Meyer … - Diabetes care, 2008 - Am Diabetes Assoc OBJECTIVE—Polycystic ovary syndrome (PCOS) is an insulin-resistant state with
insulin resistance being an established therapeutic target; however, measurement
of insulin resistance remains challenging. We aimed to 1) determine serum ... Cited by 12 - Related articles - All 11 versions
R Mathur, CJ Alexander, J Yano, B Trivax, R … - American Journal of Obstetrics & Gynecology, 2008 - nursing2008.com Reprints: Ricardo Azziz, MD, MPH, MBA, Department of Obstetrics/Gynecology,
Cedars-Sinai Medical Center, 8635 W. Third St., Suite 160W, Los Angeles, CA
90048. azzizr@cshs.org. ... Metformin as treatment for PCOS-associated ... Cited by 11 - Related articles - Cached - All 4 versions
- ►oxfordjournals.org D Romualdi, B Costantini, L Selvaggi, M … - Human Reproduction, 2008 - ESHRE BACKGROUND: Metformin was reported to improve the alterations of endothelial
reactivity in normal-weight subjects with polycystic ovary syndrome (PCOS). The
aim of the present study was to investigate the mechanisms of action of ... Cited by 7 - Related articles - All 6 versions
